InvestorsHub Logo
icon url

XenaLives

08/04/17 2:52 PM

#113998 RE: Steady_T #113995

I do think that this would all be insider info -



For example, he can say "the super responders continue to hold the initial gains they made" that is not insider information.

He could say "the overall benefits we saw earlier are holding"

He could say "The results are not as promising as they first appeared but there are still better than no treatment"



In spite of the fact that MacFarlane is not subject to U.S. law he must necessarily have a confidentiality agreement with the company and he is bound by that. He would not want to put himself in the position of breaching confidentiality.

icon url

frrol

08/04/17 3:02 PM

#114006 RE: Steady_T #113995

PIs sign NDAs and what you proposed would indeed be covered under them. He can discuss only what has already been revealed by the company, which is a public entity. MacFarlane could be sued by the company if it comes to regulatory harm and would lose his reputation as a reliable PI for any CRO or biotech.